Chen‐Chen Kan
- Virology top 10%
- HIV Research and Treatment 5
- Oncology top 10%
- Peptidase Inhibition and Analysis 2
-
- Signaling Pathways in Disease 2
- Ubiquitin and proteasome pathways 2
-
- Protease and Inhibitor Mechanisms 2
- Toxicology top 10%
-
- Herpesvirus Infections and Treatments 4
- Cytomegalovirus and herpesvirus research 4
-
- HIV/AIDS drug development and treatment 3
- Co-authors
- Stephen A. MargosiakMichael R. GehringDavid A. MatthewsChristopher PinkoDarin VanderpoolZuzana HostomskaCheryl A. JansonPing Chen
- Cited by
- VirologyOncologyMolecular Biology
- Partner nations
- United States
In The Last Decade
Chen‐Chen Kan
15 papers receiving 870 citations
Peers
Comparison fields: 5 of 82
- Virology 57
- Oncology 241
- Molecular Biology 604
- Cancer Research 111
- Toxicology 25
Countries citing papers authored by Chen‐Chen Kan
This map shows the geographic impact of Chen‐Chen Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Chen Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Chen Kan more than expected).
Fields of papers citing papers by Chen‐Chen Kan
This network shows the impact of papers produced by Chen‐Chen Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Chen Kan. The network helps show where Chen‐Chen Kan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chen‐Chen Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 25 | |
| 2 | 2002 | 20 | |
| 3 | 2002 | 2 | |
| 4 | 2000 | 164 | |
| 5 | 1999 | 161 | |
| 6 | 1998 | 43 | |
| 7 | 1998 | 28 | |
| 8 | 1997 | 4 | |
| 9 | 1996 | 119 | |
| 10 | 1996 | 65 | |
| 11 | 1995 | 7 | |
| 12 | 1995 | 39 | |
| 13 | 1995 | 32 | |
| 14 | 1994 | 169 | |
| 15 | 1992 | 20 |
About Chen‐Chen Kan
Chen‐Chen Kan is a scholar working on Virology, Physiology, Cancer Research, Infectious Diseases and Oncology, having authored 15 papers that have together received 898 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), Herpesvirus Infections and Treatments (4 papers), Cytomegalovirus and herpesvirus research (4 papers), HIV/AIDS drug development and treatment (3 papers), Signaling Pathways in Disease (2 papers), Peptidase Inhibition and Analysis (2 papers), Ubiquitin and proteasome pathways (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Virology (57 citations), Oncology (241 citations), Molecular Biology (604 citations), Cancer Research (111 citations) and Toxicology (25 citations). Chen‐Chen Kan has collaborated with scholars based in United States. Frequent co-authors include Stephen A. Margosiak, Michael R. Gehring, David A. Matthews, Christopher Pinko, Darin Vanderpool, Zuzana Hostomska, Cheryl A. Janson, Ping Chen, Katherine M. Welsh and Eleanor F. Howland. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, Cell, Current Topics in Medicinal Chemistry and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.